Think About The Big Picture! Delivering More Inclusive And Accessible Opportunities

Failing to recruit and retain patients results in 86% of all trials not meeting their enrollment deadlines and 30% of Phase III trials failing –ultimately driving up costs and risk. in addition to improving how trials retain patients, they must also consider the diversification and generalizability of the study. If insufficiently diverse data is provided, approvals and medications may be restricted to the population demographic of the study. If we think about the big picture, we can reduce the risk of running trials while expanding into new communities, increasing access for any patient and any site that wants to participate. Learn how focusing on patients and sites can drive results for trials.